The future outlook on allergen immunotherapy in children: 2018 and beyond
Abstract Allergen immunotherapy (AIT) is the only currently available immune-modifying and aetiological treatment for patients suffering from IgE-mediated diseases. In childhood, it represents a suitable therapeutic option to intervene during the early phases of respiratory allergic diseases such as...
Saved in:
Main Authors: | Stefania Arasi (Author), Giovanni Corsello (Author), Alberto Villani (Author), Giovanni Battista Pajno (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2018-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Kawasaki disease epidemic: pitfalls
by: Romina Gallizzi, et al.
Published: (2020) -
ALLERGEN-SPECIFIC IMMUNOTHERAPY IN CHILDREN WITH POLLINOSIS
by: R. M. Torshkhoeva, et al.
Published: (2014) -
Decorating and loading ghosts with allergens for allergen immunotherapy
by: Songwe Fanuel, et al.
Published: (2017) -
Omalizumab in children with severe allergic disease: a case series
by: Giuseppe Crisafulli, et al.
Published: (2019) -
New modalities of allergen immunotherapy
by: Manish Ramesh, et al.
Published: (2018)